The rise of Sildenafil initially drove a surge for the drug industry, nevertheless recent changes present a murky scenario for investors. Generic versions are eroding profits, and ongoing legal battles add more https://haleemaippe433984.blogthisbiz.com/48881141/the-blue-pill-and-the-pharmaceutical-industry-a-volatile-play